Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Lipocine Inc (LPCN)

Lipocine Inc (LPCN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 97,120
  • Shares Outstanding, K 88,291
  • Annual Sales, $ 0 K
  • Annual Income, $ -20,960 K
  • 60-Month Beta 0.38
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.09
Trade LPCN with:

Options Overview Details

View History
  • Implied Volatility 83.21%
  • Historical Volatility 41.75%
  • IV Percentile 3%
  • IV Rank 4.35%
  • IV High 583.64% on 05/11/21
  • IV Low 60.47% on 09/20/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 402
  • Volume Avg (30-Day) 379
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 11,988
  • Open Int (30-Day) 17,055

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.05
  • Number of Estimates 2
  • High Estimate -0.04
  • Low Estimate -0.05
  • Prior Year -0.07
  • Growth Rate Est. (year over year) +28.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0300 +7.77%
on 09/21/21
1.3900 -20.14%
on 08/30/21
-0.2200 (-16.54%)
since 08/27/21
3-Month
1.0300 +7.77%
on 09/21/21
1.5200 -26.97%
on 07/06/21
-0.3900 (-26.00%)
since 06/25/21
52-Week
1.0300 +7.77%
on 09/21/21
2.4200 -54.13%
on 01/22/21
-0.3100 (-21.83%)
since 09/25/20

Most Recent Stories

More News
Lipocine to Present at The Cantor Fitzgerald Virtual Global Healthcare Conference

/PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the Company will present at the Cantor Fitzgerald...

LPCN : 1.1100 (+0.91%)
Lipocine to Present at The H.C. Wainwright 23rd Annual Global Investment Conference

/PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the Company will present at the H.C. Wainwright 23rd...

LPCN : 1.1100 (+0.91%)
Lipocine's LPCN 1144 Met Non-Alcoholic Steatohepatitis ("NASH") Resolution Regulatory Endpoint in Phase 2 LiFT Study

/PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced positive topline 36-week results from its Phase 2...

LPCN : 1.1100 (+0.91%)
Lipocine: Q2 Earnings Snapshot

SALT LAKE CITY (AP) _ Lipocine Inc. (LPCN) on Thursday reported a loss of $6.8 million in its second quarter.

LPCN : 1.1100 (+0.91%)
Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2021

/PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced financial results for the second quarter ended , and...

LPCN : 1.1100 (+0.91%)
Thinking about buying stock in Verb Technology, Casper Sleep, Millendo Therapeutics, Lipocine, or Hepion Pharmaceuticals?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for VERB, CSPR, TPST, LPCN, and HEPA.

LPCN : 1.1100 (+0.91%)
HEPA : 1.5800 (+1.94%)
TPST : 14.88 (+2.27%)
VERB : 1.8500 (+3.35%)
CSPR : 4.99 (+2.46%)
Clarus Therapeutics Announces Comprehensive Settlement of Patent Litigation With Lipocine

Clarus and Lipocine (NASDAQ: LPCN) agreed to settle all outstanding claims in the patent infringement lawsuit brought against Clarus by Lipocine and to further resolve a patent interference between the...

LPCN : 1.1100 (+0.91%)
Lipocine Announces Settlement With Clarus Therapeutics

/PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that it has entered into a global settlement and license...

LPCN : 1.1100 (+0.91%)
Lipocine To Present At The Ladenburg Thalmann Healthcare Conference

/PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the Company will present at the Ladenburg Thalmann...

LPCN : 1.1100 (+0.91%)
Lipocine Announces Presentations at The International Liver Congress™ 2021 Digital Event

/PRNewswire/ -- Lipocine Inc. (Nasdaq: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that clinical data will be presented at The International...

LPCN : 1.1100 (+0.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Lipocine, Inc. is a specialty pharmaceutical company. It develops pharmaceutical products for use in men's and women's health. The Company's lead product candidate, LPCN 1021, is in Phase 3 and is targeted to treat symptoms of low testosterone for men in need of testosterone replacement therapy. Its...

See More

Key Turning Points

3rd Resistance Point 1.1900
2nd Resistance Point 1.1500
1st Resistance Point 1.1300
Last Price 1.1100
1st Support Level 1.0700
2nd Support Level 1.0300
3rd Support Level 1.0100

See More

52-Week High 2.4200
Fibonacci 61.8% 1.8890
Fibonacci 50% 1.7250
Fibonacci 38.2% 1.5610
Last Price 1.1100
52-Week Low 1.0300

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar